Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Perspective Therapeutics (CATX) Liabilities and Shareholders Equity (2016 - 2025)

Perspective Therapeutics' Liabilities and Shareholders Equity history spans 15 years, with the latest figure at $294.8 million for Q3 2025.

  • For Q3 2025, Liabilities and Shareholders Equity fell 24.63% year-over-year to $294.8 million; the TTM value through Sep 2025 reached $1.3 billion, up 10.64%, while the annual FY2024 figure was $341.1 million, 248.45% up from the prior year.
  • Liabilities and Shareholders Equity for Q3 2025 was $294.8 million at Perspective Therapeutics, down from $310.7 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $391.2 million in Q3 2024 and bottomed at $58.1 million in Q4 2022.
  • The 5-year median for Liabilities and Shareholders Equity is $110.5 million (2023), against an average of $174.5 million.
  • The largest annual shift saw Liabilities and Shareholders Equity surged 756.2% in 2021 before it fell 24.63% in 2025.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $67.3 million in 2021, then dropped by 13.62% to $58.1 million in 2022, then skyrocketed by 68.51% to $97.9 million in 2023, then soared by 248.45% to $341.1 million in 2024, then fell by 13.57% to $294.8 million in 2025.
  • Per Business Quant, the three most recent readings for CATX's Liabilities and Shareholders Equity are $294.8 million (Q3 2025), $310.7 million (Q2 2025), and $329.3 million (Q1 2025).